In 2021, the U.S. Food and Drug Administration (FDA), Health Canada, and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) collaboratively identified ten…
The conversation on psychedelics around the world continues to evolve, with more and more emerging clinical data highlighting their potential to treat mental health…
The European Parliament could have helped to stimulate R&D into new drugs for rare diseases if it had not stuck so closely to the…